Aprea Therapeutics is a clinical-stage biopharmaceutical company pioneering the development of novel anticancer therapies targeting the tumor suppressor protein, p53.
Aprea Therapeutics is a clinical-stage biopharmaceutical company pioneering the development of novel anticancer therapies targeting the tumor suppressor protein, p53.